{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:18:45Z","timestamp":1794032325128,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The role of cytokines in the pathogenesis of febrile seizures (FSs) is unclear, and information regarding cytokine production outside of FS episodes is scarce.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In our controlled follow-up study of patients with FSs, we compared the levels of 12 serum cytokines after the patients\u2019 first FSs, during febrile episodes without FSs, after recurrent FSs, during healthy periods after FSs, and between patients and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two-hundred fifty-one patients with first FS participated in the study, of whom 17 (mean age 1.6 years, SD 0.7) with recurrent FSs completed the protocol as required by the sample size calculations. The mean IL-1RA level was higher after the first FSs (2580\u2009pg\/mL, SD 1516) than during febrile episodes without FSs (1336\u2009pg\/mL, SD 1364, <jats:italic>P<\/jats:italic>\u2009=\u20090.006) and healthy periods after FSs (474\u2009pg\/mL, SD 901, <jats:italic>P<\/jats:italic>\u2009=\u20090.001). IL-1RA levels were also higher during first (2580\u2009pg\/mL) and recurrent FSs (2666\u2009pg\/mL, SD 1747) in comparison with febrile controls (746\u2009pg\/mL, SD 551) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001 and <jats:italic>P<\/jats:italic>\u2009=\u20090.001, respectively), but there was no difference in the IL-1RA between febrile episodes without FSs and febrile controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with FSs produce stronger inflammatory reactions during febrile episodes with FSs compared with febrile episodes without FSs and febrile controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>In patients with FSs, IL-1RA was higher following first FS than during febrile episodes without FSs and healthy periods after FSs.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>IL-1RA was higher in patients with FSs following first and recurrent FSs than in febrile controls.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>There was no significant difference in IL-1RA between febrile episodes of patients without FSs and febrile controls.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Using IL-1RA as a surrogate marker of IL-1 axis activity, our results indicate that patients with FSs produced stronger inflammatory reactions during FS episodes but not during other febrile episodes or healthy periods after FSs.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Cytokines may play a role in pathogenesis of FSs.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-022-02282-7","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T19:06:38Z","timestamp":1663959998000},"page":"1574-1581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Recurrent febrile seizures and serum cytokines: a controlled follow-up study"],"prefix":"10.1038","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-1572","authenticated-orcid":false,"given":"Maria K.","family":"Hautala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli M.","family":"Helander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tytti M-L","family":"Pokka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla V.","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki M. J.","family":"Rantala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti K.","family":"Uhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo J.","family":"Korkiam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virpi","family":"Glumoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi H.","family":"Mikkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2282_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1542\/peds.61.5.720","volume":"61","author":"KB Nelson","year":"1978","unstructured":"Nelson, K. B. & Ellenberg, J. H. Prognosis in children with febrile seizures. Pediatrics 61, 720\u2013727 (1978).","journal-title":"Pediatrics"},{"key":"2282_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/brain\/awab260","volume":"145","author":"L Skotte","year":"2022","unstructured":"Skotte, L. et al. Genome-wide association study of febrile seizures implicates fever response and neuronal excitability genes. Brain 145, 555\u2013568 (2022).","journal-title":"Brain"},{"key":"2282_CR3","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","volume":"23","author":"B Viviani","year":"2003","unstructured":"Viviani, B. et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23, 8692\u20138700 (2003).","journal-title":"J. Neurosci."},{"key":"2282_CR4","first-page":"497","volume":"292","author":"S Wang","year":"2002","unstructured":"Wang, S., Cheng, Q., Malik, S. & Yang, J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharm. Exp. Ther. 292, 497\u2013504 (2002).","journal-title":"J. Pharm. Exp. Ther."},{"key":"2282_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.braindev.2008.11.013","volume":"31","author":"JG Heida","year":"2009","unstructured":"Heida, J. G., Mosh\u00e9, S. L. & Pittman, Q. J. The role of interleukin-1beta in febrile seizures. Brain Dev. 31, 388\u2013393 (2009).","journal-title":"Brain Dev."},{"key":"2282_CR6","doi-asserted-by":"publisher","first-page":"11534","DOI":"10.1073\/pnas.190206797","volume":"97","author":"A Vezzani","year":"2000","unstructured":"Vezzani, A. et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl Acad. Sci. USA 97, 11534\u201311539 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2282_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.seizure.2018.04.023","volume":"59","author":"A Kwon","year":"2018","unstructured":"Kwon, A. et al. Cytokine levels in febrile seizure patients: a systematic review and meta-analysis. Seizure 59, 5\u201310 (2018).","journal-title":"Seizure"},{"key":"2282_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1046\/j.1528-1157.2002.02002.x","volume":"43","author":"M Virta","year":"2002","unstructured":"Virta, M., Hurme, M. & Helminen, M. Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 43, 920\u2013923 (2002).","journal-title":"Epilepsia"},{"key":"2282_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.seizure.2018.04.004","volume":"58","author":"J Ha","year":"2018","unstructured":"Ha, J. et al. Interleukin-4 and tumor necrosis factor-alpha levels in children with febrile seizures. Seizure 58, 156\u2013162 (2018).","journal-title":"Seizure"},{"key":"2282_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0974-7","volume":"14","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. Analysis of plasma multiplex cytokines and increased level of IL-10 and IL-1Ra cytokines in febrile seizures. J. Neuroinflammation. 14, 200 (2017); erratum 14, 226 (2017).","journal-title":"J. Neuroinflammation."},{"key":"2282_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archpediatrics.2009.137","volume":"163","author":"T Strengell","year":"2009","unstructured":"Strengell, T. et al. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch. Pediatr. Adolesc. Med. 163, 799\u2013804 (2009).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"2282_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0887-8994(01)00380-0","volume":"26","author":"M Virta","year":"2002","unstructured":"Virta, M., Hurme, M. & Helminen, M. Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. Pediatr. Neurol. 26, 192\u2013195 (2002).","journal-title":"Pediatr. Neurol."},{"key":"2282_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cellimm.2010.02.013","volume":"262","author":"MA Wallet","year":"2010","unstructured":"Wallet, M. A., Wallet, S. M., Guiulfo, G., Sleasman, J. W. & Goodenow, M. M. IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell Immunol. 262, 84\u201388 (2010).","journal-title":"Cell Immunol."},{"key":"2282_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87, 2095\u20132147 (1996).","journal-title":"Blood"},{"key":"2282_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.20358","volume":"57","author":"C Dub\u00e9","year":"2005","unstructured":"Dub\u00e9, C., Vezzani, A., Behrens, M., Bartfai, T. & Baram, T. Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 57, 152\u2013155 (2005); erratum 57, 609 (2005).","journal-title":"Ann. Neurol."},{"key":"2282_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.seizure.2020.11.007","volume":"84","author":"M Hautala","year":"2020","unstructured":"Hautala, M. et al. Respiratory viruses and febrile response in children with febrile seizures: a cohort study and embedded case-control study. Seizure 84, 69\u201377 (2020).","journal-title":"Seizure"},{"key":"2282_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-135","volume":"8","author":"J Choi","year":"2011","unstructured":"Choi, J., Min, H. J. & Shin, J. S. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J. Neuroinflammation 8, 135 (2011).","journal-title":"J. Neuroinflammation"},{"key":"2282_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/08830738020170101501","volume":"17","author":"S Haspolat","year":"2002","unstructured":"Haspolat, S. et al. Interleukin-1beta, tumor necrosis factor-alpha, and nitrite levels in febrile seizures. J. Child Neurol. 17, 749\u2013751 (2002); erratum 18, 118 (2003).","journal-title":"J. Child Neurol."},{"key":"2282_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-016-0250-y","volume":"42","author":"SF Azab","year":"2016","unstructured":"Azab, S. F. et al. Serum and CSF adiponectin, leptin, and interleukin 6 levels as adipocytokines in Egyptian children with febrile seizures: a cross-sectional study. Ital. J. Pediatr. 42, 38 (2016).","journal-title":"Ital. J. Pediatr."},{"key":"2282_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.seizure.2019.01.008","volume":"65","author":"S \u015eahin","year":"2019","unstructured":"\u015eahin, S., Uysal, S., Yent\u00fcr, S. P. & Ka\u00e7ar, A. Reduced cerebrospinal fluid levels of interleukin-10 in children with febrile seizures. Seizure 65, 94\u201397 (2019).","journal-title":"Seizure"},{"key":"2282_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3345\/kjp.2014.57.10.440","volume":"57","author":"A Mahyar","year":"2014","unstructured":"Mahyar, A. et al. Serum interleukin-1beta and tumor necrosis factor-alpha in febrile seizures: is there a link? Korean J. Pediatr. 57, 440\u2013444 (2014).","journal-title":"Korean J. Pediatr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02282-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T14:12:35Z","timestamp":1683727955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2282"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02282-7","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from the guardians of the participating children and from the adult study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}